You are here

  • Home
  • Online First
  • Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al
Free

Authors

  1. Correspondence to Prof. Dr. Patrick Verschueren; Patrick.verschueren{at}uzleuven.be
View Full Text

Citation

Stouten V, Westhovens R, Pazmino S, et al
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al
Annals of the Rheumatic Diseases Published Online First: 30 June 2021. doi: 10.1136/annrheumdis-2021-220857

Publication history

  • Received June 7, 2021
  • Accepted June 8, 2021
  • First published June 30, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.